VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia

Figure 1

Thrombocyte levels (red line) and C-reactive protein (CRP) (blue line) during the disease course. It also illustrates the uncomplicated levels during the first 40 months, progressing into spiking levels as the clinical course changes and turns more complicated.